Nasdaq: FATE
Fate Therapeutics insiders
The officers, directors and 10% owners of Fate Therapeutics, Inc. who hold the most stock, valued at the live FATE price.
$1.01
FATE today −$40K (−3.81%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 2
- Their FATE stock
- $686K
- Market value
- $123M
- Held by ranked insiders
- 0.56%
Insiders by value of FATE holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | William H. Rastetter | Director | 642,424 | $649K | 0.53% | 8559th |
| 2 | Robert S. Epstein | Director | 36,331 | $37K | <0.1% | 12894th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Fate Therapeutics; see each profile for the filing.